Compare Stocks: ONMD, LUCY, OPRX, and HCAT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HCAT Health Catalyst	$1.73 +1.8%	$1.95	$0.96 ▼ $3.62	$127.94M	1.53	575,589 shs	582,423 shs
LUCY Innovative Eyewear	$0.87 +0.3%	$0.84	$0.65 ▼ $2.24	$7.47M	2.76	10.89 million shs	186,220 shs
ONMD OneMedNet	$0.68 -1.0%	$0.66	$0.49 ▼ $4.22	$40.65M	1.12	317,726 shs	74,851 shs
OPRX OptimizeRx	$7.17 -5.7%	$7.09	$4.54 ▼ $22.25	$143.15M	1.09	226,375 shs	78,512 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HCAT Health Catalyst	+1.76%	+2.37%	+0.58%	+5.49%	-49.12%
LUCY Innovative Eyewear	+0.27%	-7.57%	+24.81%	-2.13%	-52.59%
ONMD OneMedNet	-0.98%	+19.54%	+2.88%	+16.19%	-18.38%
OPRX OptimizeRx	-5.66%	-10.82%	+4.52%	+35.80%	-59.70%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HCAT Health Catalyst	$1.73 +1.8%	$1.95	$0.96 ▼ $3.62	$127.94M	1.53	575,589 shs	582,423 shs
LUCY Innovative Eyewear	$0.87 +0.3%	$0.84	$0.65 ▼ $2.24	$7.47M	2.76	10.89 million shs	186,220 shs
ONMD OneMedNet	$0.68 -1.0%	$0.66	$0.49 ▼ $4.22	$40.65M	1.12	317,726 shs	74,851 shs
OPRX OptimizeRx	$7.17 -5.7%	$7.09	$4.54 ▼ $22.25	$143.15M	1.09	226,375 shs	78,512 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HCAT Health Catalyst	+1.76%	+2.37%	+0.58%	+5.49%	-49.12%
LUCY Innovative Eyewear	+0.27%	-7.57%	+24.81%	-2.13%	-52.59%
ONMD OneMedNet	-0.98%	+19.54%	+2.88%	+16.19%	-18.38%
OPRX OptimizeRx	-5.66%	-10.82%	+4.52%	+35.80%	-59.70%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HCAT Health Catalyst	2.18	Hold	$2.45	41.62% Upside
LUCY Innovative Eyewear	1.50	Reduce	N/A	N/A
ONMD OneMedNet	1.00	Sell	N/A	N/A
OPRX OptimizeRx	2.56	Moderate Buy	$11.43	59.39% Upside

Current Analyst Ratings Breakdown

Latest ONMD, LUCY, OPRX, and HCAT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	OPRX OptimizeRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
8/24/2026	ONMD OneMedNet	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	HCAT Health Catalyst	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$3.00 ➝ $1.80
8/14/2026	OPRX OptimizeRx	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$11.00
8/14/2026	OPRX OptimizeRx	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
8/14/2026	OPRX OptimizeRx	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Outperform	$9.00 ➝ $11.00
8/13/2026	OPRX OptimizeRx	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$12.00
8/13/2026	HCAT Health Catalyst	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Equal Weight	$1.75 ➝ $1.50
8/11/2026	OPRX OptimizeRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
8/11/2026	HCAT Health Catalyst	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$2.50 ➝ $2.00
7/28/2026	HCAT Health Catalyst	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 9/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HCAT Health Catalyst	$311.14M	0.42	$2.16 per share	0.80	$3.47 per share	0.50
LUCY Innovative Eyewear	$2.66M	2.82	N/A	N/A	$1.69 per share	0.51
ONMD OneMedNet	$1.36M	29.60	N/A	N/A	($0.06) per share	-11.32
OPRX OptimizeRx	$109.43M	1.23	$0.93 per share	7.72	$6.88 per share	1.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HCAT Health Catalyst	-$177.97M	-$3.68	N/A	N/A	N/A	-90.61%	-1.83%	-0.80%	11/9/2026 (Estimated)
LUCY Innovative Eyewear	-$7.59M	-$1.29	N/A	N/A	N/A	-225.26%	-88.90%	-80.34%	11/12/2026 (Estimated)
ONMD OneMedNet	-$2.80M	-$0.16	N/A	N/A	N/A	-584.20%	N/A	-521.20%	N/A
OPRX OptimizeRx	$5.13M	$0.23	31.18	10.54	N/A	4.66%	9.44%	7.11%	11/5/2026 (Estimated)

Latest ONMD, LUCY, OPRX, and HCAT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	LUCY Innovative Eyewear	-$0.37	-$0.26	+$0.11	-$0.26	$0.90 million	$1.01 million
8/14/2026	Q2 2026	ONMD OneMedNet	N/A	-$0.04	N/A	-$0.04	N/A	$0.29 million
8/12/2026	Q2 2026	OPRX OptimizeRx	$0.1111	$0.16	+$0.0489	-$0.04	$20.20 million	$20.50 million
8/6/2026	Q2 2026	HCAT Health Catalyst	$0.0299	$0.04	+$0.0101	-$0.55	$69.09 million	$70.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HCAT Health Catalyst	N/A	N/A	N/A	N/A	N/A
LUCY Innovative Eyewear	N/A	N/A	N/A	N/A	N/A
ONMD OneMedNet	N/A	N/A	N/A	N/A	N/A
OPRX OptimizeRx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HCAT Health Catalyst	1.51	2.70	2.70
LUCY Innovative Eyewear	N/A	12.05	8.09
ONMD OneMedNet	N/A	0.28	0.28
OPRX OptimizeRx	0.14	5.58	5.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HCAT Health Catalyst	85.00%
LUCY Innovative Eyewear	0.96%
ONMD OneMedNet	0.95%
OPRX OptimizeRx	76.47%

Insider Ownership

Company	Insider Ownership
HCAT Health Catalyst	19.40%
LUCY Innovative Eyewear	1.66%
ONMD OneMedNet	50.20%
OPRX OptimizeRx	7.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HCAT Health Catalyst	1,200	75.26 million	60.66 million	Optionable
LUCY Innovative Eyewear	9	8.61 million	8.47 million	Not Optionable
ONMD OneMedNet	2	59.29 million	29.52 million	N/A
OPRX OptimizeRx	100	18.84 million	17.42 million	Optionable

ONMD, LUCY, OPRX, and HCAT Headlines

Recent News About These Companies

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

September 8 at 7:30 AM | globenewswire.com

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

September 2, 2026 | globenewswire.com

OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts

August 31, 2026 | americanbankingnews.com

OptimizeRx Corp. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts

August 26, 2026 | marketbeat.com

AWM Investment Company Inc. Invests $1.38 Million in OptimizeRx Corp. $OPRX

August 26, 2026 | marketbeat.com

OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript

August 19, 2026 | finance.yahoo.com

OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says

August 14, 2026 | marketbeat.com

Renaissance Technologies LLC Has $1.36 Million Stock Position in OptimizeRx Corp. $OPRX

August 14, 2026 | marketbeat.com

OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...

August 13, 2026 | uk.finance.yahoo.com

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

August 13, 2026 | finance.yahoo.com

OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition

August 13, 2026 | seekingalpha.com

OptimizeRx Q2 Earnings Call Highlights

August 12, 2026 | marketbeat.com

OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript

August 12, 2026 | seekingalpha.com

OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates

August 12, 2026 | zacks.com

OptimizeRx (NASDAQ:OPRX) Announces Earnings Results, Beats Estimates By $0.05 EPS

August 12, 2026 | marketbeat.com

OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline

August 12, 2026 | tipranks.com

OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

August 12, 2026 | globenewswire.com

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

July 29, 2026 | globenewswire.com

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer

July 23, 2026 | globenewswire.com

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent

June 30, 2026 | globenewswire.com

OptimizeRx Launches AI-Powered Natural Language Audience Builder for DSP and Media Planning Platforms

June 25, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

ONMD, LUCY, OPRX, and HCAT Company Descriptions

Health Catalyst NASDAQ:HCAT

$1.73 +0.03 (+1.76%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$1.72 0.00 (-0.29%)

As of 09/9/2026 07:59 PM Eastern

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Innovative Eyewear NASDAQ:LUCY

$0.87 +0.00 (+0.27%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$0.86 -0.01 (-1.02%)

As of 09/9/2026 07:10 PM Eastern

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

OneMedNet NASDAQ:ONMD

$0.68 -0.01 (-0.98%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$0.67 -0.01 (-0.74%)

As of 09/9/2026 06:15 PM Eastern

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

OptimizeRx NASDAQ:OPRX

$7.17 -0.43 (-5.66%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$7.08 -0.09 (-1.19%)

As of 09/9/2026 07:30 PM Eastern

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ONMD, LUCY, OPRX, and HCAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ONMD, LUCY, OPRX, and HCAT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ONMD, LUCY, OPRX, and HCAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ONMD, LUCY, OPRX, and HCAT Company Descriptions

Health Catalyst NASDAQ:HCAT

Innovative Eyewear NASDAQ:LUCY

OneMedNet NASDAQ:ONMD

OptimizeRx NASDAQ:OPRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ONMD, LUCY, OPRX, and HCAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ONMD, LUCY, OPRX, and HCAT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ONMD, LUCY, OPRX, and HCAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ONMD, LUCY, OPRX, and HCAT Company Descriptions

Health Catalyst NASDAQ:HCAT

Innovative Eyewear NASDAQ:LUCY

OneMedNet NASDAQ:ONMD

OptimizeRx NASDAQ:OPRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools